August 20, 2014

While nobody thought 2013-14 cough-cold sales would reach as high in comparison to the year before, no one expected the season to come down as much as it did.

August 8, 2014

Prestige Brands' Matthew Mannelly, CEO, president and director, on Thursday outlined a number of ways that Prestige is utilizing social media to enhance its brand offering. 

April 15, 2014

Prestige Brands on Tuesday announced the signing of a purchase agreement for the acquisition of Hydralyte in Australia and New Zealand from the Hydration Pharmaceuticals Trust of Victoria, Australia.

February 7, 2014

Cough-cold suppliers are presently operating in a challenging environment, noted Matthew Mannelly, Prestige Brands CEO, president and director, during a conference call Thursday.

August 8, 2013

The coming cough-cold season is difficult to project. On one hand, this year's cough-cold incidence will be going against very strong illness rate numbers from last year. In addition, with both McNeil Consumer and Novartis Consumer supporting the relaunch of a number of cough-cold products, the category is expected to be very promotional this season, a factor that could squeeze margins.

July 9, 2013

Prestige Brands Holdings announced its acquisition of Care Pharmaceuticals of Bondi Junction, New South Wales, Australia, a privately held marketer and distributor of over-the-counter healthcare brands for children and adults.

May 16, 2013

The booming 2012-2013 cough-cold season may not have come with a fresh set of challenges for the 2013-2014 season.

February 7, 2013

Reporting on the third quarter ended Dec. 31, Prestige Brands' CEO Matthew Mannelly told analysts he is "cautiously optimistic" regarding cough-cold reorders given the high consumption levels at retail in late December through January.

May 17, 2012

Prestige Brands on Thursday morning announced the launch of Dramamine for Kids.

May 17, 2012

Prestige Brands closed out its fiscal 2012 ended March 31 on a high note with $441.1 million in revenues for the year, up 31.1%. And fiscal 2013 is looking promising as the company will have full-year contributions from its 17 acquired over-the-counter brands from GlaxoSmithKline.

December 20, 2011

Prestige on Tuesday acquired 17 over-the-counter brands from GlaxoSmithKline for a total of $660 million in cash.

March 9, 2011

You can expect to see quite a bit of co-promotional activity between PediaCare and Little Remedies in the 2011-2012 cough-cold season, Prestige Brands president and CEO Matthew Mannelly told investors Wednesday morning at the Bank of America Merrill Lynch 2011 Consumer Conference held here.

March 4, 2011

Prestige Brands on Friday named Paul Hennessey VP operations.

February 9, 2011

Prestige Brands posted gains of 22.7% in revenue, reaching $90.6 million for its third quarter ended Dec. 31.

December 17, 2010

Prestige Brands Holdings on Thursday announced that it has entered into a definitive agreement to acquire the assets associated with the Dramamine business in the United States from McNeil Consumer Healthcare for $76 million in cash.

August 4, 2010

Prestige Brands credited the strength of its over-the-counter business model for its 20% increase in...